Breast Cancer—Epidemiology, Risk Factors, Classification, Prognostic Markers, and Current Treatment Strategies—An Updated Review
Open accessThe DOI matches its Crossref record; 272 of the 272 references it cites were found in a registry or an index.
Abstract
Breast cancer (BC) is the most frequently diagnosed cancer in women worldwide with more than 2 million new cases in 2020. Its incidence and death rates have increased over the last three decades due to the change in risk factor profiles, better cancer registration, and cancer detection. The number of risk factors of BC is significant and includes both the modifiable factors and non-modifiable factors. Currently, about 80% of patients with BC are individuals aged >50. Survival depends on both stage and molecular subtype. Invasive BCs comprise wide spectrum tumors that show a variation concerning their clinical presentation, behavior, and morphology. Based on mRNA gene expression levels, BC can be divided into molecular subtypes (Luminal A, Luminal B, HER2-enriched, and basal-like). The molecular subtypes provide insights into new treatment strategies and patient stratifications that impact the management of BC patients. The eighth edition of TNM classification outlines a new staging system for BC that, in addition to anatomical features, acknowledges biological factors. Treatment of breast cancer is complex and involves a combination of different modalities including surgery, radiotherapy, chemotherapy, hormonal therapy, or biological therapies delivered in diverse sequences.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–272 of 272
Sun, L., Zhu, Y., Qian, Q., & Tang, L. (2018) · Medicine · doi:10.1097/md.0000000000011220 · Cited by 104
Prognostic and predictive role of tumour-associated macrophages in HER2 positive breast cancer
Honkanen, T. J., Tikkanen, A., Karihtala, P., Mäkinen, M. J., Väyrynen, J. P., & Koivunen, J. P. (2019) · Scientific Reports · doi:10.1038/s41598-019-47375-2 · Cited by 104
Zhang, Q., Liu, J., Ao, N., Yu, H., Peng, Y., Ou, L., & Zhang, S. (2020) · Scientific Reports · doi:10.1038/s41598-020-58134-z · Cited by 104
Kilincalp, S., Çoban, Ş., Akinci, H., Hamamcı, M., Karaahmet, F., Coşkun, Y., Üstün, Y., Şimşek, Z., Erarslan, E., & Yüksel, İ. (2015) · European Journal of Cancer Prevention · doi:10.1097/cej.0000000000000092 · Cited by 103
Green tea compounds in breast cancer prevention and treatment
Li, M.-J. (2014) · World Journal of Clinical Oncology · doi:10.5306/wjco.v5.i3.520 · Cited by 98
Zhang, X., Zhao, W., Yu, Y., Qi, X., Song, L., Zhang, C., Li, G., & Yang, L. (2020) · World Journal of Surgical Oncology · doi:10.1186/s12957-020-01952-2 · Cited by 98
Prat, A., Galván, P., Jimenez, B., Buckingham, W., Jeiranian, H. A., Schaper, C., Vidal, M., Álvarez, M., Díaz, S., Ellis, C., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-0630 · Cited by 97
Schacht, D. V., Yamaguchi, K., Lai, J., et al. (2014) · American Journal of Roentgenology · doi:10.2214/ajr.13.11553 · Cited by 94
kConFab Investigators, Hopper, J. L., Dite, G. S., MacInnis, R. J., Liao, Y., Zeinomar, N., Knight, J. A., Southey, M. C., Milne, R. L., Chung, W. K., et al. (2018) · Breast Cancer Research · doi:10.1186/s13058-018-1056-1 · Cited by 94
Radiation Therapy in the Management of Breast Cancer
Yang, J. T., & Ho, A. Y. (2013) · Surgical Clinics of North America · doi:10.1016/j.suc.2013.01.002 · Cited by 93
Pregnancy duration and breast cancer risk
Husby, A., Wohlfahrt, J., Øyen, N., & Melbye, M. (2018) · Nature Communications · doi:10.1038/s41467-018-06748-3 · Cited by 93
ALCOHOL CONSUMPTION AND THE RISK OF BREAST CANCER
CHU, S. Y., LEE, N. C., WINGO, P. A., & WEBSTER, L. A. (1989) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a115419 · Cited by 92
Diet and risk of breast cancer
Kotepui, M. (2016) · Współczesna Onkologia · doi:10.5114/wo.2014.40560 · Cited by 92
Ding, Y., Zhang, C., Zhang, J., Zhang, N., Li, T., Fang, J., Zhang, Y., Zuo, F., Tao, Z., Tang, S., et al. (2017) · International Journal of Oncology · doi:10.3892/ijo.2017.3945 · Cited by 90
Validation of the 8th AJCC prognostic staging system for breast cancer in a population-based setting
Abdel-Rahman, O. M. (2017) · Breast Cancer Research and Treatment · doi:10.1007/s10549-017-4577-x · Cited by 88
Everolimus in the Treatment of Metastatic Breast Cancer
Royce, M., & Osman, D. I. (2015) · Breast Cancer Basic and Clinical Research · doi:10.4137/bcbcr.s29268 · Cited by 86
Qureshi, H., Linden, M. D., Divine, G., & Raju, U. (2006) · American Journal of Clinical Pathology · doi:10.1309/wmx7drwtfvqp2lqt · Cited by 85
A review of adjuvant hormonal therapy in breast cancer
Jones, K. L., & Buzdar, A. U. (2004) · Endocrine Related Cancer · doi:10.1677/erc.1.00594 · Cited by 85
Colomer, R., Aranda, I., Albanell, J., García‐Caballero, T., Ciruelos, E., López‐García, M. Á., Cortés, J., Rojo, F., Martín, M., & Palacios-Calvo, J. (2017) · Clinical & Translational Oncology · doi:10.1007/s12094-017-1800-5 · Cited by 83
Breast cancer risk in relation to abortion: Results from the EPIC study
REEVES, G. K., Kan, S. W., Key, T., Tjønneland, A. M., Olsen, A., Overvad, K., Peeters, P. H. M., Clavel‐Chapelon, F., Paolettí, X., Berrino, F., et al. (2006) · International Journal of Cancer · doi:10.1002/ijc.22001 · Cited by 82
Emerging Trends in Family History of Breast Cancer and Associated Risk
Shiyanbola, O. O., Arao, R. F., Miglioretti, D. L., Sprague, B. L., Hampton, J. M., Stout, N. K., Kerlikowske, K. M., Braithwaite, D., Buist, D. S. M., Egan, K. M., et al. (2017) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-17-0531 · Cited by 81
Circular RNA; a new biomarker for breast cancer: A systematic review
Jahani, S., Nazeri, E., Majidzadeh‐A, K., Jahani, M., & Esmaeili, R. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29558 · Cited by 81
p53 as a Specific Prognostic Factor in Triple-negative Breast Cancer
Chae, B. J., Bae, J. S., Lee, A., Park, W. C., Seo, Y., Song, B. J., Kim, J. S., & Jung, S. S. (2009) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyp007 · Cited by 80
Antibiotics and Risk of Breast Cancer: Up to 9 Years of Follow-up of 2.1 Million Women
Friedman, G. D., Oestreicher, N., Chan, J., Quesenberry, C. P., Udaltsova, N., & Habel, L. A. (2006) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0401 · Cited by 77
The role of tumor-associated macrophages in breast carcinoma invasion and metastasis.
Yang, J., Li, X., Liu, X., & Liu, Y. (2015) · Europe PMC (PubMed Central) · Cited by 77
Kumar, P., Liu, J., Hooke, J. A., Kovatich, A. J., Kvecher, L., Shriver, C. D., & Hu, H. (2019) · Scientific Reports · doi:10.1038/s41598-019-44339-4 · Cited by 76
Alcohol consumption and the risk of breast cancer.
Coronado, G. D., Beasley, J. M., & Livaudais, J. C. (2011) · PubMed · Cited by 74
Horne, H. N., Oh, H., Sherman, M. E., Palakal, M. M., Hewitt, S. M., Schmidt, M. K., Milne, R. L., Hardisson, D., Benitez, J. J., BLOMQVIST, C. P., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-23733-4 · Cited by 73
Stemmer, S. M., Steiner, M., Rizel, S., Soussan‐Gutman, L., Ben-Baruch, N. E., Bareket‐Samish, A., Geffen, D. B., Nisenbaum, B., Isaacs, K., Fried, G., et al. (2017) · npj Breast Cancer · doi:10.1038/s41523-017-0034-6 · Cited by 70
Tran, A. M., Chalbatani, G. M., Berland, L., Santos, M. C. D. L., Raj, P. S., Jalali, S. A., Gharagouzloo, E., Ivan, C., Dragomir, M. P., & Călin, G. A. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00050 · Cited by 69
Cigarette smoking increases risk for breast cancer in high-risk breast cancer families.
Couch, F. J., Cerhan, J. R., Vierkant, R. A., Grabrick, D. M., Therneau, T. M., Pankratz, V. S., Hartmann, L. C., Olson, J. E., Vachon, C. M., & Sellers, T. A. (2001) · PubMed · Cited by 68
Orgeás, C. C., Hall, P., Rosenberg, L., & Czene, K. (2008) · Breast Cancer Research · doi:10.1186/bcr2212 · Cited by 67
The prognostic value of Ki67 in systemically untreated patients with node-negative breast cancer
Pathmanathan, N., Balleine, R. L., Jayasinghe, U. W., Bilinski, K. L., Provan, P. J., Byth, K., Bilous, A. M., Salisbury, E., & Boyages, J. (2014) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2013-201793 · Cited by 66
Preoperative lymphocyte-to-monocyte ratio predicts breast cancer outcome: A meta-analysis
Hu, R.-J., Liu, Q., Ma, J.-Y., Zhou, J., & Liu, G. (2018) · Clinica Chimica Acta · doi:10.1016/j.cca.2018.05.031 · Cited by 66
Billgren, L. E. R. A.-M. A.-M. (1999) · Acta Oncologica · doi:10.1080/028418699431186 · Cited by 65
Antidepressant medication use and breast cancer risk
Wernli, K. J., Hampton, J. M., Trentham‐Dietz, A., & Newcomb, P. A. (2009) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1719 · Cited by 64
MiR-195 Suppresses Cervical Cancer Migration and Invasion Through Targeting Smad3
Zhou, Q., Han, L., Zhou, Y., & Li, Y. (2016) · International Journal of Gynecological Cancer · doi:10.1097/igc.0000000000000686 · Cited by 64
Biganzoli, E. M., Coradini, D., Ambrogi, F., Garibaldi, J. M., Lisboa, P. J. G., Soria, D., Green, A. R., Pedriali, M., Piantelli, M., Querzoli, P., et al. (2011) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyq227 · Cited by 62
Molecular Biomarkers for Contemporary Therapies in Hormone Receptor-Positive Breast Cancer
Freelander, A., Brown, L. J., Parker, A. J., Segara, D., Portman, N., Lau, B., & Lim, E. (2021) · Genes · doi:10.3390/genes12020285 · Cited by 62
Denosumab for the treatment of bone metastases in breast cancer: evidence and opinion
Steger, G. G., & Bartsch, R. (2011) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758834011412656 · Cited by 61
Lawlor, D. A., Jüni, P., Ebrahim, S., & Egger, M. (2003) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(02)00568-1 · Cited by 60
Antidepressant medication use and breast cancer risk: a case-control study
Steingart, A. B., Cotterchio, M., Kreiger, N., & Sloan, M. (2003) · International Journal of Epidemiology · doi:10.1093/ije/dyg155 · Cited by 60
Hoskins, L. M., Roy, K. M., Peters, J. A., Loud, J. T., & Greene, M. H. (2008) · Families Systems & Health · doi:10.1037/a0012914 · Cited by 59
Johns, L. E., Jones, M. E., Schoemaker, M. J., McFadden, E. C., Ashworth, A., & Swerdlow, A. J. (2018) · British Journal of Cancer · doi:10.1038/bjc.2017.359 · Cited by 58
Breast conserving therapy: A surgical technique where little can mean more
Rahman, G. A. (2011) · Journal of Surgical Technique and Case Report · doi:10.4103/2006-8808.78459 · Cited by 55
Low-dose aspirin and breast cancer risk: results by tumour characteristics from a randomised trial
Zhang, S. M., Cook, N. R., Manson, J. E., Lee, I.-M. M., & Buring, J. E. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604240 · Cited by 55
High risk of breast cancer in women with biallelic pathogenic variants in CHEK2
Rainville, I. R., Hatcher, S., Rosenthal, E., Larson, K., Bernhisel, R., Meek, S. M., Gorringe, H., Mundt, E., & Manley, S. (2020) · Breast Cancer Research and Treatment · doi:10.1007/s10549-020-05543-3 · Cited by 52
Precision Medicine in Hormone Receptor-Positive Breast Cancer
Nasrazadani, A., Thomas, R. A., Oesterreich, S., & Lee, A. V. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00144 · Cited by 51
Tang, Y., Zhou, X., Ji, J., Chen, L., Cao, J., Luo, J., & Zhang, S. (2015) · The International Journal of Biological Markers · doi:10.5301/jbm.5000160 · Cited by 50
The emerging role of circular RNAs in breast cancer
Zhou, S., Chen, W., Yang, S., Xu, Z., Hu, J.-H., Zhang, H.-D., Zhong, S., & Tang, J. (2019) · Bioscience Reports · doi:10.1042/bsr20190621 · Cited by 50
Wu, J., Zhao, Y., Zhou, X., & Qin, X. Y. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109647 · Cited by 44
Temporal trends in breast cancer survival by race and ethnicity: A population-based cohort study
Hill, D. A., Prossnitz, E. R., Royce, M., & Nibbe, A. M. (2019) · PLoS ONE · doi:10.1371/journal.pone.0224064 · Cited by 43
Re-Evaluating E-Cadherin and β-Catenin
Borcherding, N. C., Cole, K. S., Kluz, P., Jorgensen, M., Kolb, R. H., Bellizzi, A. M., & Zhang, W. (2018) · American Journal Of Pathology · doi:10.1016/j.ajpath.2018.05.003 · Cited by 42
Furrer, D., Paquet, C., Jacob, S., & Diorio, C. (2018) · IntechOpen eBooks · doi:10.5772/intechopen.78271 · Cited by 42
Biologic therapy for advanced breast cancer: recent advances and future directions
Tarantino, P., Morganti, S., & Curigliano, G. (2020) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2020.1752176 · Cited by 42
Wang, X., Hui, T., Wang, M.-Q., Liu, H., Li, R., & Song, Z. (2019) · Oncology Research and Treatment · doi:10.1159/000496548 · Cited by 39
Artificial Light at Night and Cancer: Global Study
Al-Naggar, R. A., & Anil, S. (2016) · Europe PMC (PubMed Central) · doi:10.22034/apjcp.2016.17.10.4661 · Cited by 38
Videnros, C., Selander, J., Wiebert, P., Albin, M. C., Plato, N., Borgquist, S., Manjer, J., & Gustavsson, P. (2019) · International Archives of Occupational and Environmental Health · doi:10.1007/s00420-019-01479-4 · Cited by 37
The Potential of Circular RNAs as Cancer Biomarkers
Brown, J. R., & Chinnaiyan, A. M. (2020) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-20-0796 · Cited by 34
Hypothesis: is antibiotic use associated with breast cancer?
Velicer, C. M., Lampe, J. W., Heckbert, S. R., Potter, J. D., & Taplin, S. H. (2003) · Cancer Causes & Control · doi:10.1023/a:1026323424792 · Cited by 33
Bae, S. Y., Nam, S. J., Jung, Y. S., Lee, S. B., Park, B.-W., Lim, W., Jung, S. H., Yang, H. W., & Jung, S. P. (2018) · Breast Cancer Research and Treatment · doi:10.1007/s10549-018-4928-2 · Cited by 33
A Review of Fam-Trastuzumab Deruxtecan-nxki in HER2-Positive Breast Cancer
Nguyen, X., Hooper, M., Borlagdan, J., & Palumbo, A. (2021) · Annals of Pharmacotherapy · doi:10.1177/1060028021998320 · Cited by 31
Whole-organ analysis of TGF-β-mediated remodelling of the tumour microenvironment by tissue clearing
Kubota, S. I., Takahashi, K., Mano, T., Matsumoto, K., Katsumata, T., Shi, S., Tainaka, K., Ueda, H. R., Ehata, S., & Miyazono, K. (2021) · Communications Biology · doi:10.1038/s42003-021-01786-y · Cited by 27
ZMYND8 Expression in Breast Cancer Cells Blocks T-Lymphocyte Surveillance to Promote Tumor Growth
Wang, Y., Luo, M., Chen, Y., Wang, Y., Zhang, B., Ren, Z., Bao, L., Wang, Y., Wang, J. E., Fu, Y., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-20-1710 · Cited by 24
Influence of Physical Activity and Exercise on Innate Immunity
Hoffinan-Goetz, L. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.1998.tb01629.x · Cited by 23
Breast cancer family history and allele-specific DNA methylation in the legacy girls study
Wu, H.-C., Do, C., Andrulis, I. L., John, E. M., Daly, M. B., Buys, S. S., Chung, W. K., Knight, J. A., Bradbury, A. R., Keegan, T. H. M., et al. (2018) · Epigenetics · doi:10.1080/15592294.2018.1435243 · Cited by 23
Riccardi, F., Colantuoni, G., Diana, A., Mocerino, C., Carten�, G., Lauria, R., Febbraro, A., Nuzzo, F., Addeo, R., Marano, O., et al. (2018) · Molecular and Clinical Oncology · doi:10.3892/mco.2018.1672 · Cited by 22
Palbociclib for the treatment of postmenopausal breast cancer – an update
Steger, G. G., Gnant, M., & Bartsch, R. (2015) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2016.1133590 · Cited by 21
Hu, Z., Liu, L., Xie, N., Lü, J., Liu, Z., Tang, Y., Wang, Y., Yang, J., & Ouyang, Q. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.00829 · Cited by 21
Familial Risks and Estrogen Receptor-Positive Breast Cancer in Hong Kong Chinese Women
Tse, L. A., Li, M., Chan, W.-C., Kwok, C.-H., Leung, S.-L., Wu, Ç., Yu, I. T.-S., Yu, W.-C., Lao, X. Q., Wang, X., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0120741 · Cited by 17
Deen, N. N. A., Lanman, N. A., Chittiboyina, S., Lelièvre, S. A., Nasr, R., Nassar, F. J., zu Dohna, H., Haidar, M. A., & Talhouk, R. (2021) · Scientific Reports · doi:10.1038/s41598-021-82057-y · Cited by 16
Relationship of Breast Cancer with Ovarian Cancer
Çelik, A., Acar, M., Moroski-Erkul, C. A., Gündüz, E., & Gündüz, M. (2015) · InTech eBooks · doi:10.5772/59682 · Cited by 14
Cited by
Almansour, N. M. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.836417 · Cited by 397
A Basic Review on Estrogen Receptor Signaling Pathways in Breast Cancer
Clusan, L., Ferrière, F., Flouriot, G., & Pakdel, F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076834 · Cited by 382
Healthy Lifestyle and Cancer Risk: Modifiable Risk Factors to Prevent Cancer
Marino, P., Mininni, M., Deiana, G., Marino, G., Divella, R., Bochicchio, I., Giuliano, A., Lapadula, S., Lettini, A. R., & Sanseverino, F. (2024) · Nutrients · doi:10.3390/nu16060800 · Cited by 240
“…Investigation into Cancer and Nutrition) study showed that consuming alcohol at a young age, before the first pregnancy, significantly increases the risk of developing BC [169], inducing morphological alterations to the breast tissue, predisposing it to the development of this disease [158,170].”
BackgroundTargeting Breast Cancer: An Overlook on Current Strategies
Iacopetta, D., Ceramella, J., Baldino, N., Sinicropi, M., & Catalano, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043643 · Cited by 88
Wu, H., Van Der Pol, W. J., Dubois, L. G., Morrow, C. D., & Tollefsbol, T. O. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24109015 · Cited by 27
“Introduction Breast cancer (BC) is one of the most frequently diagnosed cancers in women worldwide, and its incidence and mortality rates have been increasing over the past decades [1].”
Background
Metadata
- Authors
- Łukasiewicz, S., Czeczelewski, M., Forma, A., Baj, J., Sitarz, R., & Stanisławek, A.
- Venue
- Cancers
- Publisher
- MDPI AG
- Published
- 2021-08-25
- Volume
- 13
- Issue
- 17
- Pages
- 4287
- ISSN
- 2072-6694 (ISSN-L)
- OpenAlex
- W3193347331
- Cited by
- 1,960
- References
- 272
- FWCI
- 83.89
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.